Welch Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.1M Buy
634,264
+7,436
+1% +$651K 1.99% 24
2026
Q1
$53.4M Buy
626,828
+13,652
+2% +$1.22M 2.01% 26
2025
Q4
$48.5M Sell
613,176
-72,609
-11% -$5.69M 1.87% 25
2025
Q3
$54.8M Buy
685,785
+20,744
+3% +$1.77M 2.14% 22
2025
Q2
$60.5M Buy
665,041
+9,689
+1% +$885K 2.53% 13
2025
Q1
$60.8M Buy
655,352
+23,733
+4% +$2.13M 2.68% 15
2024
Q4
$57.3M Buy
631,619
+9,137
+1% +$872K 2.58% 15
2024
Q3
$64.6M Sell
622,482
-2,383
-0.4% -$243K 2.81% 12
2024
Q2
$60.6M Sell
624,865
-2,948
-0.5% -$272K 2.91% 9
2024
Q1
$56.5M Sell
627,813
-4,079
-0.6% -$346K 2.8% 13
2023
Q4
$50.4M Buy
631,892
+12,755
+2% +$959K 2.71% 15
2023
Q3
$44M Buy
619,137
+12,584
+2% +$941K 2.61% 19
2023
Q2
$46.7M Buy
606,553
+7,970
+1% +$617K 2.68% 18
2023
Q1
$45M Buy
598,583
+15,050
+3% +$1.12M 2.62% 18
2022
Q4
$46M Buy
583,533
+19,588
+3% +$1.47M 2.63% 20
2022
Q3
$39.6M Buy
563,945
+14,759
+3% +$1.16M 2.58% 18
2022
Q2
$44M Buy
549,186
+20,837
+4% +$1.63M 2.69% 17
2022
Q1
$40.1M Buy
528,349
+23,032
+5% +$1.82M 2.29% 24
2021
Q4
$43.1M Buy
505,317
+27,149
+6% +$2.12M 2.52% 17
2021
Q3
$36.1M Buy
478,168
+12,538
+3% +$996K 2.45% 21
2021
Q2
$37.9M Buy
465,630
+15,019
+3% +$1.23M 2.58% 21
2021
Q1
$35.5M Buy
450,611
+12,601
+3% +$988K 2.56% 19
2020
Q4
$37.5M Sell
438,010
-4,360
-1% -$361K 3% 10
2020
Q3
$34.1M Buy
442,370
+19,365
+5% +$1.48M 2.98% 11
2020
Q2
$31M Buy
423,005
+2,677
+0.6% +$190K 2.9% 15
2020
Q1
$27.9M Buy
420,328
+31,950
+8% +$2.25M 2.98% 17
2019
Q4
$26.7M Buy
388,378
+7,145
+2% +$487K 2.63% 25
2019
Q3
$28M Buy
381,233
+966
+0.3% +$70.1K 2.88% 21
2019
Q2
$27.3M Buy
380,267
+4,979
+1% +$353K 2.91% 21
2019
Q1
$25.7M Buy
375,288
+23,652
+7% +$1.53M 2.83% 22
2018
Q4
$20.9M Sell
351,636
-3,781
-1% -$237K 2.56% 24
2018
Q3
$23.8K Buy
355,417
+23,750
+7% +$1.58M 2.48% 25
2018
Q2
$21.5M Buy
331,667
+16,935
+5% +$1.11M 2.68% 24
2018
Q1
$22.6M Buy
314,732
+79,786
+34% +$5.74M 2.86% 20
2017
Q4
$17.7M Buy
234,946
+5,500
+2% +$402K 2.75% 21
2017
Q3
$16.7M Buy
229,446
+3,201
+1% +$231K 2.79% 24
2017
Q2
$16.8M Buy
226,245
+15,585
+7% +$1.16M 2.8% 19
2017
Q1
$15.4M Buy
210,660
+8,957
+4% +$627K 2.9% 23
2016
Q4
$13.2M Buy
201,703
+7,647
+4% +$524K 2.58% 26
2016
Q3
$14.4M Sell
194,056
-1,197
-0.6% -$88.5K 2.86% 19
2016
Q2
$14.3M Sell
195,253
-48,689
-20% -$3.47M 2.91% 19
2016
Q1
$17.2M Buy
243,942
+5,217
+2% +$347K 2.88% 18
2015
Q4
$15.9M Buy
238,725
+3,876
+2% +$258K 2.86% 20
2015
Q3
$14.9M Buy
234,849
+8,409
+4% +$549K 2.88% 18
2015
Q2
$14.8M Buy
226,440
+6,343
+3% +$430K 2.8% 21
2015
Q1
$15.3K Buy
220,097
+6,890
+3% +$476K 2.8% 19
2014
Q4
$14.8M Buy
213,207
+10,986
+5% +$742K 2.85% 19
2014
Q3
$13.2M Buy
202,221
+5,110
+3% +$337K 2.73% 20
2014
Q2
$13.4M Buy
197,111
+3,133
+2% +$210K 2.78% 20
2014
Q1
$12.6M Buy
193,978
+2,746
+1% +$173K 2.85% 20
2013
Q4
$12.5M Buy
191,232
+1,726
+0.9% +$110K 2.83% 14
2013
Q3
$11.2M Buy
189,506
+6,198
+3% +$367K 2.76% 18
2013
Q2
$10.5M Buy
+183,308
New +$10.9M 2.73% 25

Other funds holding CL

Welch Group's CL Position: Q2 2026 in Review

Welch Group increased its Colgate-Palmolive (CL) stake by 1.2% in Q2 2026, buying an estimated $651K and bringing the position to 634,264 shares worth $58.1M. The position accounts for 1.99% of the portfolio, ranked #24.

Welch Group first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $64.6M in Q3 2024. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Welch Group held 634,264 shares of Colgate-Palmolive worth $58.1M as of Q2 2026.
  • Welch Group bought 7,436 Colgate-Palmolive shares in Q2 2026, an estimated $651K.
  • Colgate-Palmolive made up 1.99% of Welch Group's portfolio in Q2 2026, its #24 holding.
  • Welch Group first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Welch Group's Colgate-Palmolive position peaked at $64.6M in Q3 2024.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Welch Group's 13F filing for Q2 2026, filed 23 Jul 2026.